Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/26/2010US20100216706 Ghrelin Protects Substantia Nigra Dopamine Neurons
08/26/2010US20100216697 Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
08/26/2010US20100216694 Antidiabetic tricyclic compounds
08/26/2010US20100216689 Cytotoxic t cell activator comprising ep4 agonist
08/26/2010US20100216169 Method for Detecting and Prognosing Pre-Cancerous Cells Using 5, 10, 15, 20-Tetrakis (Carboxyphenyl) Porphine
08/26/2010US20100215833 Coating for medical device and method of manufacture
08/26/2010US20100215783 Antioxidant Compositions, Beverage Formulations Thereof, and Methods of Increasing Antioxidant Capability
08/26/2010US20100215782 Novel mitochondrial uncoupling methods and compositions for enhancing adipocyte thermogenesis
08/26/2010US20100215780 Method for treating onychoschizia
08/26/2010US20100215779 Compositions and Methods for Treating Disorders Associated with Salt or Fluid Retention
08/26/2010US20100215775 Use of c10-c14-alkanediols in the preparation of a composition for the prophylaxis and/or treatment of malassezia-induced dandruff formation
08/26/2010US20100215774 Film comprising nitroglycerin
08/26/2010US20100215773 Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular Permeability
08/26/2010US20100215772 Aminopyrimidines useful as kinase inhibitors
08/26/2010US20100215771 Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
08/26/2010US20100215768 Nutritional supplement
08/26/2010US20100215762 Edible composition for treating cutaneous signs of ageing
08/26/2010US20100215759 Pharmaceutical compounds
08/26/2010US20100215756 Pharmaceutical preparations containing highly volatile silicones
08/26/2010US20100215754 Delivery System for Functional Compounds
08/26/2010US20100215752 Policosanol nanoparticles
08/26/2010US20100215751 Methods and compositions for treating recurrent cancer
08/26/2010US20100215750 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
08/26/2010US20100215749 TEMPERATURE- AND pH-RESPONSIVE POLYMER COMPOSITIONS
08/26/2010US20100215748 Functionalized adhesive medical gel
08/26/2010US20100215746 Prevention of cisplatin induced deafness
08/26/2010US20100215744 Hydroxypropyl Substitution Used to Regulate Dissolution of a Chemical
08/26/2010US20100215743 Composition and drug delivery of bisphosphonates
08/26/2010US20100215742 Drug active in neuropathic pain
08/26/2010US20100215741 Pharmaceutical compounds
08/26/2010US20100215740 Taste-masked orally disintegrating tablets of memantine hydrochloride
08/26/2010US20100215739 Low dose topiramate / phentermine composition and methods of use thereof
08/26/2010US20100215738 Prebiotic formulations and methods of use
08/26/2010US20100215737 Combination pharmaceutical compositions
08/26/2010US20100215736 Oral dosage form providing fast adsorption of drug
08/26/2010US20100215735 Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds
08/26/2010US20100215734 Pharmaceutical compositions
08/26/2010US20100215732 Ingestible implement for weight control
08/26/2010US20100215731 Method for improving cartilage repair and/or preventing cartilage degeneration in a joint
08/26/2010US20100215730 Compositions for Nasal Administration of Phenothiazines
08/26/2010US20100215729 Oligonucleotide analogues incorporating 5-aza-cytosine therein
08/26/2010US20100215728 Skincare Methods
08/26/2010US20100215727 Stabilized picoplatin dosage form
08/26/2010US20100215725 Pharmaceutical composition containing idebenone for the treatment of liver disorders
08/26/2010US20100215724 Microcapsule Nanotube Devices for Targeted Delivery of Therapeutic Molecules
08/26/2010US20100215723 Wound Dressing with Antimicrobial Gauze and Bonding Agent
08/26/2010US20100215719 Polyarylates for drug delivery and tissue engineering
08/26/2010US20100215716 Compositions and methods for coating orthopedic implants
08/26/2010US20100215713 Scaffolds for follicle transplantation
08/26/2010US20100215710 Beta-2 Adrenergic Receptor Agonists and Antagonists and Modulation of Wound Healing
08/26/2010US20100215708 Coating of devices with effector compounds
08/26/2010US20100215707 Activated creatinine and precursors thereof as antibacterial agents, compositions and products containing such agents and uses thereof
08/26/2010US20100215704 Methods and products for improving wound healing
08/26/2010US20100215693 Immunological herpes simplex virus antigens and methods for use thereof
08/26/2010US20100215689 Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health
08/26/2010US20100215687 Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health
08/26/2010US20100215685 Acyl pseudodipeptides which carry a functionalized auxiliary arm
08/26/2010US20100215680 Replikin peptides and antibodies therefor
08/26/2010US20100215679 Methods and compositions for treating tularemia
08/26/2010US20100215672 Preparation process and utilization of Poncirus compositions having anti-allergic and antianaphylactic properties
08/26/2010US20100215668 Methods for the treatment or prevention of hemorrhagic conditions
08/26/2010US20100215665 Mixed lineage kinases and metabolic disorders
08/26/2010US20100215661 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215660 Kruppel-like factors and fat regulation
08/26/2010US20100215659 Functionalized surgical adhesives
08/26/2010US20100215652 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215646 Immunostimulatory activity of palindromic immune modulatory oligonucleotides (imo) containing different lengths of palindromic segments
08/26/2010US20100215645 determining increased risk for developing positive autoantibody rheumatoid factor (RF+) Rheumatoid Arthritis (RA) in human by testing nucleic acid from the human to detect the nucleotide content of a single nucleotide polymorphism (SNP) at position 101 of any of SEQ ID NOS:10,916-49,582 and 50,231
08/26/2010US20100215644 Analysis of nodes in cellular pathways
08/26/2010US20100215642 Synthetic rna-based agonists of tlr7
08/26/2010US20100215641 Screening method for compounds that reduce er stress
08/26/2010US20100215638 Method for treatment of prostate cancer and screening of patients benefiting from said method
08/26/2010US20100215637 Agent for the Treatment of Hormone-Dependent Disorders and Uses Thereof
08/26/2010US20100215635 Small molecules to induce weight loss or to reduce weight gain
08/26/2010US20100215634 Visfatin therapeutic agents for the treatment of acne and other conditions
08/26/2010US20100215633 Method for feeding dairy cows and dairy goats supplements to increase the C2 hxroylated estrogen (C2) to C16 hydroxlated estrogen (C16) ratio secreted in their urine
08/26/2010US20100215620 The co-culture method of sphingomonas sp. bacterial strain and aspergillus sp. fungus strain, new anti-cancer and antibiotic glionitrins derived from this co-culture method, and pharmaceutical composition containing glionitrins or pharmaceutically acceptable salt thereof as an active ingredient
08/26/2010US20100215619 Hla peptide therapy
08/26/2010US20100215618 Novel compounds - 644
08/26/2010US20100215616 Hepatitis C Virus Inhibitors
08/26/2010US20100215613 PVA Particle for Temporary Embolic Material and Production Process Thereof, and Temporary Embolic Material
08/26/2010US20100215603 Body Surface Protecting Composition
08/26/2010US20100215594 Tyrosinase Inhibitors
08/26/2010US20100215590 Micronization Method
08/26/2010US20100215589 Carbamate Stereoisomer
08/26/2010US20100215582 Liposome and method for producing liposome
08/26/2010US20100215579 Phen-naphthalene and phen-quinoline derivatives and their use for binding and imaging amyloid plaques
08/26/2010US20100215574 Process for producing an injectable medicament preparation
08/26/2010US20100212667 Drug capsules for dry powder inhalers
08/26/2010DE102009001041A1 Notfallset zur Herstellung eines Arzneimittels zur nasalen Anwendung von Opioiden bei Atemnot Emergency kit for the preparation of a medicament for nasal administration of opioids for breathlessness
08/26/2010DE102008046995B4 2-Ethoxy-benzoesäurederivat 2-ethoxy-benzoic acid
08/26/2010CA2788777A1 Policosanol nanoparticles
08/26/2010CA2777743A1 Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof
08/26/2010CA2759667A1 Particles comprising drospirenone encapsulated in a polymer
08/26/2010CA2753698A1 Methods and compositions for inhibiting cellular proliferation and surgical adhesion
08/26/2010CA2753436A1 Estrogen receptor ligands and methods of use thereof
08/26/2010CA2753387A1 Novel cephem compounds useful for the treatment of bacterial infections
08/26/2010CA2753313A1 Inhibitors of hcv ns5a
08/26/2010CA2753274A1 Phytosterol dispersions
08/26/2010CA2753205A1 Amidobipiperidinecarboxylate m1 allosteric agonists, analogs and derivatives thereof, and methods of making and using same
1 ... 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 ... 7860